Invests in
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
Lists including Joshua
Work Experience
2021
Co-founder, CEO
2021
Psylo (SMW21) is a small molecule biotech start-up developing next-generation therapeutics inspired by psychedelic compounds that exist in nature. Psylo is targeting the 5-HT2A receptor for the treatment of neuropsychiatric conditions based on the emerging promise of psilocybin. Our mission is to produce novel take-home medications which extend the healing potential of psychedelics to a broader patient population.
2022
Limited Partner
2022
2021
Limited Partner
2021
2016
Limited Partner
2016
2015
Angel Investor
2015
Various angel investments such as Kanna Health, Finless Foods, Fable Foods, Stockheld Dreamery, Pana Travel (acquired), and Clarus Power.
2019
Limited Partner
2019
2018
Limited Partner
2018
2018 - 2022
Founder
2018 - 2022
OutBranch partners with digital media businesses to launch operations in APAC. Past projects include Tubi, SpokenLayer, and Emodo.
2015 - 2017
Vice President
2015 - 2017
After TVN was acquired we grew revenue by 4x, and launched two new APAC offices, including our New Zealand office (which had me based in Auckland for a year).
2010 - 2015
Co-Founder
2010 - 2015
Internet video business backed by Netus in 2010. Acquired by Tremor Video (now Magnite) as a launchpad for APAC growth.